FDA 483 - Steri-Pharma, LLC - August 08, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Steri-Pharma, LLC in Syracuse, NY, was inspected and cited for significant deficiencies across three observations. The inspection revealed inadequate written procedures for production and process controls, particularly concerning process validation studies for drug products. Additionally, the firm failed to adequately validate its aseptic processes and did not thoroughly review unexplained discrepancies, including repeated mold recoveries in aseptic processing areas.
ID · cec013e8-5afc-4d97-aca2-5e442b76b08d